In our previous study, we found that liraglutide could inhibit the proliferation and migration of vascular smooth muscle cells induced by PDGF-BB, and reduce cell division and proliferation, through inhibiting the activation mechanism of PAH via eNOS/NO/cGMP/PKG after the induction of MCT [20]. This evidence concerns the gene PRKG1 and pulmonary arterial hypertension.